Literature DB >> 31655774

Pseudopheochromocytoma.

Divya Mamilla1, Melissa K Gonzales1, Murray D Esler2, Karel Pacak3.   

Abstract

Pseudopheochromocytoma manifests as severe, symptomatic paroxysmal hypertension without significant elevation in catecholamine and metanephrine levels and lack of evidence of tumor in the adrenal gland. The clinical manifestations are similar but not identical to those in excess circulating catecholamines. The underlying symptomatic mechanism includes augmented cardiovascular responsiveness to catecholamines alongside heightened sympathetic nervous stimulation. The psychological characteristics are probably attributed to the component of repressed emotions related to a past traumatic episode or repressive coping style. Successful management can be achieved by strong collaboration between a hypertension specialist and a psychiatrist or psychologist with expertise in cognitive-behavioral panic management.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypertension; Paroxysm; Pheochromocytoma; Pseudopheochromocytoma; Spell

Mesh:

Year:  2019        PMID: 31655774      PMCID: PMC6903402          DOI: 10.1016/j.ecl.2019.08.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  40 in total

1.  Paroxysmal hypertension due to baroreflex failure.

Authors:  T Zar; A J Peixoto
Journal:  Kidney Int       Date:  2008-03-05       Impact factor: 10.612

2.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

3.  Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.

Authors:  E L Bravo; R C Tarazi; F M Fouad; D G Vidt; R W Gifford
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

Review 4.  Labile and Paroxysmal Hypertension: Common Clinical Dilemmas in Need of Treatment Studies.

Authors:  Samuel J Mann
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

5.  Severe paroxysmal hypertension. An automatic syndrome and its relationship to repressed emotions.

Authors:  S J Mann
Journal:  Psychosomatics       Date:  1996 Sep-Oct       Impact factor: 2.386

Review 6.  Severe paroxysmal hypertension (pseudopheochromocytoma).

Authors:  Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

Review 7.  Resistant hypertension, secondary hypertension, and hypertensive crises.

Authors:  W Dallas Hall
Journal:  Cardiol Clin       Date:  2002-05       Impact factor: 2.213

8.  Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.

Authors:  Murray Esler; Elisabeth Lambert; Marlies Alvarenga; Florentia Socratous; Jeff Richards; David Barton; Ciaran Pier; Celia Brenchley; Tye Dawood; Jacqueline Hastings; Ling Guo; Deepak Haikerwal; David Kaye; Garry Jennings; Victor Kalff; Michael Kelly; Glen Wiesner; Gavin Lambert
Journal:  Stress       Date:  2007-08       Impact factor: 3.493

9.  Increased plasma dopamine in patients presenting with the pseudopheochromocytoma quandary: retrospective analysis of 10 years' experience.

Authors:  O Kuchel
Journal:  J Hypertens       Date:  1998-10       Impact factor: 4.844

Review 10.  Clonidine suppression test revisited.

Authors:  T Lenz; A Ross; P Schumm-Draeger; K L Schulte; H Geiger
Journal:  Blood Press       Date:  1998-05       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.